Amphetamine Addiction

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Amphetamine Addiction trials may be worth asking about

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingPhase 2

NCT06788587

Feasibility of Long-term, High-dose Stimulant for Methamphetamine Use Disorder

Methamphetamine use disorder (MUD) is becoming an increasing public health concern in Canada. While the evidence on the efficacy and safety of prescription psyc…

Canada80 participantsStarted 2025-07-18Updated 2026-02-23

Treatment: LDX-01 plus TAU, Placebo plus TAU

All recent trials (45 shown)

CompletedNot Applicable

NCT05380440

Preventing Parental Opioid and/or Methamphetamine Addiction Within DHS-Involved Families: PRE-FAIR

Young parents aged 16 to 30, involved in the DHS system for child welfare or self-sufficiency needs are at risk for opioid use disorder and/or methamphetamine u…

United States241 participantsStarted 2021-06-09Updated 2026-06-05

Treatment: Prevention Adaptation of Families Actively Improving Relationships (PRE-FAIR), Standard Case Management and Referral

CompletedNot Applicable

NCT06454474

Closed-loop tACS Modulation for the Core Clinical Features of Drug Addiction

Using specific EEG biomarkers in methamphetamine-dependent individuals, this study systematically probes the effect of closed-loop tACS based on brain states

China21 participantsStarted 2024-06-30

Amphetamine Addiction

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Feasibility of Long-term, High-dose Stimulant for Methamphetamine Use Disorder

All recent trials (45 shown)

Preventing Parental Opioid and/or Methamphetamine Addiction Within DHS-Involved Families: PRE-FAIR

Closed-loop tACS Modulation for the Core Clinical Features of Drug Addiction

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Feasibility of Long-term, High-dose Stimulant for Methamphetamine Use Disorder

All recent trials (45 shown)

Preventing Parental Opioid and/or Methamphetamine Addiction Within DHS-Involved Families: PRE-FAIR

Closed-loop tACS Modulation for the Core Clinical Features of Drug Addiction

Individualized Neuromodulation for the Core Clinical Features of Drug Addiction

Effects of Repetitive Transcranial Magnetic Stimulations in Patients With Amphetamine Use Disorders

The Norwegian Addiction, Pain and Trauma Study

Neurocognitive Empowerment for Addiction Treatment (NEAT) in Opioid Use Disorder and Amphetamine Use Disorder

Repetitive Transcranial Magnetic Stimulation in Amphetamine Addiction

Change the Cycle: An RCT to Prevent Injection Initiation

Robot-Assisted Intelligent Rehabilitation Treatment for Methamphetamine Use Disorders.

Non-invasive Brain Stimulation in Patients With Methamphetamine Use Disorder

Dextromethorphan, Memantine Monotherapy, or Combined Use of Dextromethorphan and Memantine in Amphetamine Addiction

Cannabioids as a New Intervention for Amphetamine Dependence

Implementation and Effectiveness of Multidiscipline-Integrated Addiction Treatment Model

The Application of Cognitive Rehabilitation Therapy for Amphetamine-type Stimulants Addiction

The Novel Addiction Assessment Study in Synthetic Drugs Addiction

Novel Intervention for Amphetamine-type Stimulants Addiction

Oxytocin HIV Meth Study

The Application of Music Therapy in Female Amphetamine Use Disorder

An Assessment of the Safety of Varenicline in Methamphetamine-dependent Volunteers

Extended Release Naltrexone for Treating Amphetamine Dependence in Iceland